1-7 of 7
David G. Oscier, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tracking Subclonal Mutations in IGHV-Mutated CLL with Progressive Disease

Matthew JJ Rose-Zerilli, PhD, Gibson Jane, PhD, Jun Wang, PhD, William J Tapper, PhD, Helen Parker, PhD, Anton Parker, Zadie Davis, Anne Catherine Gardiner, Jade Forster, Andrew J Steele, PhD, Renata Walewska, Helen McCarthy, Andrew Collins, PhD, David G Oscier, MD, Jonathan C Strefford, PhD
Journal: Blood
Blood (2014) 124 (21): 1962.
https://doi.org/10.1182/blood.V124.21.1962.1962
Published: 2014
Journal Articles

Splicing Inhibition By Spliceostatin_A Is a Promising Therapeutic Strategy in Chronic Lymphocytic Leukaemia

Marta Larrayoz, PhD, Stuart Blakemore, Rachel Dobson, BSc, Matthew Rose-Zerilli, PhD, Renata Walewska, Matthew Blunt, PhD, Minoru Yoshida, PhD, David G Oscier, MD, Mark Cragg, PhD, Andrew J Steele, PhD, Jonathan C Strefford, PhD
Journal: Blood
Blood (2014) 124 (21): 3301.
https://doi.org/10.1182/blood.V124.21.3301.3301
Published: 2014
Journal Articles

Deep-Sequencing Reveals the Molecular Landscape of Splenic Marginal Zone Lymphoma: Biological and Clinical Implications

Matthew JJ Rose-Zerilli, PhD, Marina Parry, Viktor Ljungstrom, Jane Gibson, Jun Wang, Renata Walewska, Helen Parker, PhD, Anton Parker, Zadie Davis, Anne Catherine Gardiner, Neil McIver-Brown, Christina H. Kalpadakis, MD, Aliki Xochelli, Achilles Anagnostopoulos, Claudia Fazi, PhD, David Gonzalez de Castro, PhD, Claire Dearden, MD, Guy Pratt, Richard Rosenquist, MD PhD, Margaret Ashton-Keys, Francesco Forconi, Andrew Collins, PhD, Paolo Ghia, MD PhD, Estella Matutes, MD PhD, Gerassimos A Pangalis, Kostas Stamatopoulos, David G Oscier, MD, Jonathan C Strefford, PhD
Journal: Blood
Blood (2014) 124 (21): 76.
https://doi.org/10.1182/blood.V124.21.76.76
Published: 2014
Journal Articles

Chronic Lymphocytic Leukemia Patients with IGHV Genes Carrying Only Silent Mutations Have A Longer Time From Diagnosis to Initial Therapy Than Patients Expressing B-Cell Receptors with No Somatic Mutations

Matthew Kaufman, MD, Xiao J. Yan, MD, PhD, Emanuela M. Ghia, PhD, Donna Neuberg, ScD, Laura Z. Rassenti, Ph.D., Kostas Stamatopoulos, MD, Paolo Ghia, MD, PhD, David G Oscier, MD, Frederic Davi, MD, PhD, Richard Rosenquist, MD, PhD, Chrysoula Belessi, MD, Zadie Davis, PhD, Andreas Agathangelidis, Neil Kay, MD, John C. Byrd, MD, Jennifer R Brown, MD, PhD, Kanti R. Rai, M.D., Thomas J. Kipps, M.D., Ph.D, Nicholas Chiorazzi, M.D.
Journal: Blood
Blood (2011) 118 (21): 288.
https://doi.org/10.1182/blood.V118.21.288.288
Published: 2011
Journal Articles

ZAP-70 by Flow Cytometry: Comparison of Methodologies, and with IgVH Mutational and ZAP-70 Methylation Status.

Jenny A. Orchard, MD, Oliver G. Best, PhD, Rachel E. Ibbotson, PhD, Anton E. Parker, BSc, David G. Oscier, MD
Journal: Blood
Blood (2005) 106 (11): 1181.
https://doi.org/10.1182/blood.V106.11.1181.1181
Published: 2005
Journal Articles

Gender as a Prognostic Factor in CLL. Biological Pointers to the Improved Outcome of Women.

Daniel Catovsky, MD, DSC, Estella Matutes, MD, PhD, Alison Morilla, BSc, Anna Burford, BSc, Vasantha Brito-Babapulle, PhD, Ilaria Del-Giudice, MD, Jennifer Orchard, MD, David G. Oscier, MD, Jim Halsey, PhD, Sue Richards, PhD
Journal: Blood
Blood (2004) 104 (11): 957.
https://doi.org/10.1182/blood.V104.11.957.957
Published: 2004
Journal Articles

DLEU2 , Located within the CLL 13q14 Deletion Locus, Encodes an Antisense RNA for the Putative Bicistronic RFP2/LEU5 Gene in Humans and Mouse.

Martin M. Corcoran, PhD, Marianne Hammarsund, PhD, Chaoyong Zhu, PhD, Mikael Lerner, BSc, Bagrat Kapanadze, PhD, Catharina Larsson, PhD, Lars Forsberg, PhD, Rachel E. Ibbotson, PhD, Stefan Einhorn, MD, David G. Oscier, MD, Dan Grander, MD, Olle Sangfelt, PhD
Journal: Blood
Blood (2004) 104 (11): 1540.
https://doi.org/10.1182/blood.V104.11.1540.1540
Published: 2004